होम › मल्टीपल मायलोमा › टेक्सास › Dallas
Dallas, TX में मल्टीपल मायलोमा क्लिनिकल ट्रायल
Dallas (लगभग 30 मील के भीतर) की साइटों पर मल्टीपल मायलोमा के लिए 17 अध्ययन प्रतिभागियों की तलाश में हैं। यह देखने के लिए कि कौन शामिल हो सकता है और अध्ययन टीम से कैसे संपर्क करें, एक अध्ययन खोलें।
आधिकारिक अध्ययन पाठ (अंग्रेजी)
यहाँ अध्ययन के लिए भर्ती कर रहे हैं? इसे इस पृष्ठ के शीर्ष पर फीचर करें — 30 दिनों के लिए $99 →
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
भर्ती जारीचरण 3
- Research Site, Dallas
A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
भर्ती जारीचरण 3
- Baylor University Medical Center, Dallas
A Study Comparing JNJ-79635322 and an Anti-B-cell Maturation Antigen (BCMA)xCD3 Bispecific Antibody in Participants With Relapsed or Refractory Multiple Myeloma
भर्ती जारीचरण 3
- Baylor University Medical Center, Dallas
- UT Southwestern Medical Center, Dallas
A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma
भर्ती जारीचरण 3
- University of Texas Southwestern Medical Center, Dallas
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma
भर्ती जारीचरण 2
- UT Southwestern Medical Center, Dallas
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
भर्ती जारीचरण 1/2
- University of Texas - Southwestern Medical Center /ID# 271914, Dallas
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
भर्ती जारीचरण 3
- Baylor University Medical Center, Investigational Drug Services, Department of Pharmacy, Dallas
- Baylor University Medical Center, Dallas
A Study of an MMSET Inhibitor in Patients With Relapsed and Refractory Multiple Myeloma
भर्ती जारीचरण 1
- University of Texas Southwestern Harold C. Simmons Comprehensive Cancer Center, Dallas
AZD0120 in Relapsed/Refractory Multiple Myeloma (DURGA-1)
भर्ती जारीचरण 1/2
- Research Site, Dallas
Study of AZD0120 in Newly Diagnosed Multiple Myeloma Ineligible for ASCT
भर्ती जारीचरण 3
- Research Site, Dallas
A Study to Learn About the Effects of Cemsidomide in Combination With Elranatamab in Relapsed/Refractory Multiple Myeloma Subjects
भर्ती जारीचरण 1
- Baylor University Medical Center, Dallas
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
भर्ती जारीचरण 1/2
- University of Texas - Southwestern Medical Center /ID# 274360, Dallas
A Study to Assess Adverse Events of Intravenously (IV) Infused Etentamig (ABBV-383) in Adult Participants With Relapsed or Refractory Multiple Myeloma
भर्ती जारीचरण 1
- Texas Oncology - Dallas - Worth Street /ID# 280064, Dallas
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Participants With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
भर्ती जारीचरण 1
- University of Texas Southwestern, Dallas
Frontline T-cell Engager vs Autologous Stem Cell Transplant (ASCT) and Measurable Residual Disease (MRD)-Guided Sequential Intensification thERapy in Multiple Myeloma
भर्ती जारीचरण 2
- University of Texas Southwestern, Dallas
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy
भर्ती जारीअवलोकनात्मक अध्ययन
- Ut Southwestern, Dallas
CRISPR-Edited Allogeneic Anti-BCMA CAR-T Cell Therapy in Patients With Relapsed/Refractory Multiple Myeloma
भर्ती जारीचरण 1
- University of Texas Southwestern Medical Center, Dallas
अन्य शहरों में मल्टीपल मायलोमा ट्रायल
- New York City, NY60 अध्ययन
- Boston, MA42 अध्ययन
- Atlanta, GA41 अध्ययन
- Houston, TX38 अध्ययन
- Durham, NC37 अध्ययन
- Nashville, TN32 अध्ययन
- Denver, CO27 अध्ययन
- Rochester, MN24 अध्ययन
- St. Louis, MO24 अध्ययन
- Columbus, OH24 अध्ययन
- Baldwin Park, CA23 अध्ययन
- Chicago, IL22 अध्ययन
Dallas में अन्य अध्ययन
- स्तन कैंसर55 अध्ययन
- नॉन-स्मॉल सेल लंग कैंसर52 अध्ययन
- मेटास्टेटिक कैंसर42 अध्ययन
- हृदय अस्वस्थता42 अध्ययन
- कैंसर (सभी प्रकार)37 अध्ययन
- प्रोस्टेट कैंसर36 अध्ययन
- कोलोरैक्टल कैंसर33 अध्ययन
- मोटापा30 अध्ययन
- अंडाशय का कैंसर28 अध्ययन
- मूत्राशय का कैंसर27 अध्ययन
- फेफड़ों का कैंसर27 अध्ययन
- एंडोमेट्रियल कैंसर24 अध्ययन
ClinicalTrials.gov से, 5 अक्तू॰ 2026 को प्राप्त डेटा। प्रत्येक अध्ययन अपनी योग्यता निर्धारित करता है; अध्ययन टीम तय करती है कि कौन शामिल हो सकता है।